Editorial
Welcome to the July 2014 homepage edition of i2P (Information to Pharmacists) E-Magazine.
At the commencement of 2014 i2P focused on the need for the entire profession of pharmacy and its associated industry supports to undergo a renewal and regeneration.
We are now half-way through this year and it is quite apparent that pharmacy leaders do not yet have a cohesive and clear sense of direction.
Maybe the new initiative by Woolworths to deliver clinical service through young pharmacists and nurses may sharpen their focus.
If not, community pharmacy can look forward to losing a substantial and profitable market share of the clinical services market.
Who would you blame when that happens?
But I have to admit there is some effort, even though the results are but meagre.
In this edition of i2P we focus on the need for research about community pharmacy, the lack of activity from practicing pharmacists and when some research is delivered, a disconnect appears in its interpretation and implementation.
Columns
Recent Comments
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 4 Number 1
Volume 4 Number 2
Volume 4 Number 3
Volume 4 Number 4
Volume 4 Number 5
Volume 4 Number 6
Volume 4 Number 7
Volume 4 Number 8
Volume 4 Number 9
Volume 4 Number 10
Volume 4 Number 11
Volume 5 Number 1
Volume 5 Number 2
Volume 5 Number 3
Volume 5 Number 4
Volume 5 Number 5
Volume 5 Number 6
Volume 5 Number 7
Volume 5 Number 8
Volume 5 Number 9
Volume 5 Number 10
Volume 5 Number 11
Volume 6 Number 1
Volume 6 Number 2
Volume 6 Number 3
Volume 6 Number 4
Volume 6 Number 5
Volume 6 Number 6
Health Politics
EPublications
News Flash
Newsflash Updates for July 2014
Regular weekly updates that supplement the regular monthly homepage edition of i2P.
Access and click on the title links that are illustrated
1Feature Contribution
Woolworths Pharmacy - Getting One Stage Closer
It started with “tablet” computers deployed on shelves inside the retailer Coles, specifically to provide information to consumers relating to pain management and the sale of strong analgesics.
This development was reported in i2P under the title “Coles Pharmacy Expansion and the Arid PGA Landscape”
In that article we reported that qualified information was a missing link that had come out of Coles market research as the reason to why it had not succeeded in dominating the pain market.
Of course, Woolworths was working on the same problem at the same time and had come up with a better solution - real people with good information.
5Intensive Exposition without crossing over with a supermarket
Editor's Note: The understanding of a pharmacy's presentation through the research that goes into the design of fixtures and fittings that highlight displays, is a never-ending component of pharmacy marketing.
Over the past decade, Australian pharmacy shop presentations have fallen behind in standards of excellence.
It does not take rocket science - you just have to open your eyes.
Recently, our two major supermarkets, Woolworths and Coles, have entered into the field of drug and condition information provision - right into the heartland of Australian Pharmacy.
The sure way to drive business away
I attended the Pregnancy, Baby and Children’s Expo in Brisbane recently.
What an eye and ear opening event that was!
Young Mums, mature Mums, partners of all ages, grandparents and friends……...many asking about health issues and seeking reassurances that they were doing the right thing.
1
‘Marketing Based Medicine’ – how bad is it?
It should be the scandal of the century.
It potentially affects the health of almost everyone.
Healthcare providers and consumers alike should be up in arms. But apart from coverage in a few credible news sources the problem of ‘Marketing Based Medicine,’ as psychiatrist Dr Peter Parry terms it, hasn’t as yet generated the kind of universal outrage one might expect.
Community Pharmacy Research - Are You Involved?
Government funding is always scarce and restricted.
If you are ever going to be a recipient of government funds you will need to fortify any application with evidence.
From a government perspective, this minimises risk.
I must admit that while I see evidence of research projects being managed by the PGA, I rarely see community pharmacists individually and actively engaged in the type of research that would further their own aims and objectives (and survival).
Organisational Amnesia and the Lack of a Curator Inhibits Cultural Progress
Most of us leave a tremendous impact on pharmacies we work for (as proprietors, managers, contractors or employees)—in ways we’re not even aware of.
But organisational memories are often all too short, and without a central way to record that impact and capture the knowledge and individual contributions, they become lost to time.
It is ironic that technology has provided us with phenomenal tools for communication and connection, but much of it has also sped up our work lives and made knowledge and memory at work much more ephemeral.
Academics on the payroll: the advertising you don't see
This article was first published in The Conversation and was written by Wendy Lipworth, University of Sydney and Ian Kerridge, University of Sydney
In the endless drive to get people’s attention, advertising is going ‘native’, creeping in to places formerly reserved for editorial content. In this Native Advertising series we find out what it looks like, if readers can tell the difference, and more importantly, whether they care.
i2P has republished the article as it supports our own independent and ongoing investigations on how drug companies are involved in marketing-based medicine rather than evidence-based medicine.
I’ve been thinking about admitting wrong.
Editor's Note: This is an early article by Mark Neuenschwander we have republished after the soul-searching surrounding a recent Australian dispensing error involving methotrexate.
Hmm. There’s more than one way you could take that, huh? Like Someday when I get around to it (I’m not sure) I may admit that I was wrong about something. Actually, I’ve been thinking about the concept of admitting wrong. So don’t get your hopes up. No juicy confessions this month except that I wish it were easier for me to admit when I have been wrong or made a mistake.
Brian Goldman, an ER physician from Toronto, is host of the award-winning White Coat, Black Art on CBC Radio and slated to deliver the keynote at The unSUMMIT for Bedside Barcoding in Anaheim this May. His TED lecture, entitled, “Doctors make mistakes. Can we talk about it?” had already been viewed by 386,072 others before I watched it last week.
Dispensing errors – a ripple effect of damage
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA
Most readers will be aware of recent publicity relating to dispensing errors and in particular to deaths caused by methotrexate being incorrectly packed in dose administration aids.
The Pharmacy Board of Australia (PBA), in its Communique of 13 June 2014, described a methotrexate packing error leading to the death of a patient and noted “extra vigilance is required to be exercised by pharmacists with these drugs”.
This same case was reported by A Current Affair (ACA) in its program on Friday 20 June http://aca.ninemsn.com.au/article/8863098/prescription-drug-warning
Take a vacation from your vocation
Have you ever had one of those days when all you could think was, “Gosh, do I need a vacation.”
Of course you have – because all work and no play aren’t good for anyone.
A vacation doesn’t have to be two weeks on a tropical island, or even a long weekend at the beach.
A vacation just means taking a break from your everyday activities.
A change of pace.
It doesn’t matter where.
Everyone needs a vacation to rejuvenate mentally and physically.
But did you also know that you can help boost our economy by taking some days off?
Call it your personal stimulus package.
Explainer: what is peer review?
This article was first published in the Conversation. It caught our eye because "peer review" it is one of the standards for evidence-based medicines that has also been corrupted by global pharma.
The article is republished by i2P as part of its ongoing investigation into scientific fraud and was writtenby Andre Spicer, City University London and Thomas Roulet, University of Oxford
We’ve all heard the phrase “peer review” as giving credence to research and scholarly papers, but what does it actually mean?
How does it work?
Peer review is one of the gold standards of science. It’s a process where scientists (“peers”) evaluate the quality of other scientists' work. By doing this, they aim to ensure the work is rigorous, coherent, uses past research and adds to what we already knew.
Most scientific journals, conferences and grant applications have some sort of peer review system. In most cases it is “double blind” peer review. This means evaluators do not know the author(s), and the author(s) do not know the identity of the evaluators.
The intention behind this system is to ensure evaluation is not biased.
The more prestigious the journal, conference, or grant, the more demanding will be the review process, and the more likely the rejection. This prestige is why these papers tend to be more read and more cited.
Dentists from the dark side?
While dining out with an elderly friend, I noticed that he kept his false tooth plate in his shirt pocket. He had recently had seven amalgam-filled teeth removed, because he believed that their toxins were making him sick; but his new plate was uncomfortable. He had been treated by an 'holistic dentist'. Claiming to offer a "safe and healthier alternative" to conventional dentistry, are they committed to our overall health and wellbeing or are they promoting unjustified fear, unnecessarily extracting teeth and wasting our money?
Planning for Profit in 2015 – Your key to Business Success
We are now entering a new financial year and it’s a great time to reflect on last year and highlight those things that went well and those that may have impacted negatively in the pursuit of your goals.
It's also a great to spend some time re-evaluating your personal and business short, medium and long term goals in the light of events over the last year.
The achievement of your goals will in many cases be dependent on setting and aspiring to specific financial targets. It's important that recognise that many of your personal goals will require you to generate sufficient business profits to fund those aspirations
ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use
Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company’s ReWalk Personal System for use at home and in the community.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
ReWalk, the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use, is now available throughout the United States.
Attracting and Retaining Great People
Welcome to the new financial year in Australia.
For many in business the past year has been described as a challenging period.
Adjectives are a key feature of the English language. In the business lexicon their use can be, and often is evocative and stimulate creative images. But they can also contribute to inexact, emotional perceptions.
Throughout the financial pages of newspapers and business magazines adjectives abound.
References to “hot” money draw attention and comment. The recent wave of funds from Chinese investors, keen to remove their wealth from the jurisdiction and control of government regulations is creating a potential property bubble in Australia.
Updating Your Values - Extending Your Culture
Pharmacy culture is dormant.
Being comprised of values, unless each value is continually addressed, updated or deleted, entire organisations can stagnate (or entire professions such as the pharmacy profession).
Good values offer a strong sense of security, knowing that if you operate within the boundaries of your values, you will succeed in your endeavours.
Evidence-based medicine is broken. Why we need data and technology to fix it
The following article is reprinted from The Conversation and forms up part of our library collection on evidence-based medicines.
At i2P we also believe that the current model of evidence is so fractured it will never be able to be repaired.
All that can happen is that health professionals should independently test and verify through their own investigations what evidence exists to prescribe a medicine of any potency.
Health professionals that have patients (such as pharmacists) are ideally placed to observe and record the efficacy for medicines.
All else should confine their criticisms to their evidence of the actual evidence published.
If there are holes in it then share that evidence with the rest of the world.
Otherwise, do not be in such a hurry to criticise professions that have good experience and judgement to make a good choice on behalf of their patients, simply because good evidence has not caught up with reality.
Laropiprant is the Bad One; Niacin is/was/will always be the Good One
Orthomolecular Medicine News Service, July 25, 2014
Laropiprant is the Bad One; Niacin is/was/will always be the Good One
by W. Todd Penberthy, PhD
(OMNS July 25, 2014) Niacin has been used for over 60 years in tens of thousands of patients with tremendously favorable therapeutic benefit (Carlson 2005).
In the first-person NY Times best seller, "8 Weeks to a Cure for Cholesterol," the author describes his journey from being a walking heart attack time bomb to a becoming a healthy individual.
He hails high-dose niacin as the one treatment that did more to correct his poor lipid profile than any other (Kowalski 2001).
Culture Drive & Pharmacy Renewal
Deep within all of us we have a core set of values and beliefs that create the standards of behaviour that we align with when we set a particular direction in life.
Directions may change many times over a lifetime, but with life experiences and maturity values may increase in number or gain greater depth.
All of this is embraced under one word – “culture”.
When a business is born it will only develop if it has a sound culture, and the values that comprise that culture are initially inherent in the business founder.
A sound business culture equates to a successful business and that success is often expressed in the term “goodwill” which can be eventually translated to a dollar value.
ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use
Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company’s ReWalk Personal System for use at home and in the community.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
ReWalk, the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use, is now available throughout the United States.
Pharmacy 2014 - Pharmacy Management Conference
The brave new world of health and wellness is not the enemy of Pharmacy, it is its champion.
Australian futurist, Morris Miselowski, one of the world's leading business visionaries, will present the Opening Keynote address on Pharmacy's Future in the new Health and Wellness Landscape at 2.00pm on Wednesday July 30.
Morris believes the key to better health care could already be in your pocket, with doctors soon set to prescribe iPhone apps, instead of pills.
Technology will revolutionise the health industry - a paradigm shift from healthcare to personal wellness.
Health and wellness applications on smartphones are already big news, and are dramatically changing the way we manage our personal health and everyday wellness.
Generation and Application of Community Pharmacy Research
Editor’s Note: We have had a number of articles in this issue relating to pharmacy research.
The PGA has conducted a number of research initiatives over the years, including one recently reported in Pharmacy News that resulted from an analysis of the QCPP Patient Questionnaire.
Pharmacy Guild president, George Tambassis, appears to have authored the article following, and there also appears to be a disconnect between the survey report and its target audience illustrated by one of the respondent comments published.
I have asked Mark Coleman to follow through, elaborate and comment:
Hmmm, I’m not convinced
Printer-friendly version
Send to friend
PDF version | Garry Boyd |
Garry has an interest in intellectual property (patents and trade marks), pharmacy automation and dispensary systems extending to workflows, layout and design within a pharmacy. He has a wide knowledge of the pharmacy industry having once worked for Sigma. He is also the inventor of Express Rx, one of the first Australian designed and built automated dispensing solutions for the local market. | |
A Woolworths “spokesman” (they are all still so very alpha at Woolies) has come out (excuse the expression) and declared the loss of interest in not only their “pharmacy” type trademarks but the industry of pharmacy itself.
980218 Pharmacist at Woolworths and 980219 PHARMACIST @ WOOLWORTHS, both previously registered trade marks, have been cancelled.
We can only speculate as to why this apparently momentous decision was worthy of something akin to a press conference.
Roger Corbett AO, must have near choked on his weeties at this news after leading the charge for so long. For years he assaulted the Canberra Mandarins with every imaginable statistic and reason why Woolworths should be handed pharmacy on a platter. So convinced he must have been of his own skills of persuasion (which are clearly exquisite) he had Wal-Mart ready to pounce when the Mandarins caved in.
Mr.Corbett has since moved on from Woolworths but the fact he is a Director of Wal-Mart might give a sight to the intensity of his intent at the time.
Is it really all over for Woolworths though?
I doubt it.
Woolworths have the “Select” brand registered as a trademark in a number of classes, including class 5, which is described below;
"Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides".
Let’s not trouble ourselves with the destroying of vermin or fungicides and herbicides at the moment.
Being in possession of a ridiculously suspicious nature when it comes to these tricky matters I make the observation the ubiquitous “peeled apple” does not appear on the “Select” trademark. Being the superior in-house brand, “Select”can no doubt be applied to pharmacy in the future.
It’s not a great stretch to suggest “Select Pharmacy” or “Pharmacy Select” might be better options than the two cancelled names.
Yes, yes, I’m being picky but isn’t this a bit like ignoring the best looking girl at the dance and hope that she’ll come and ask why?
The intricate nuances of delicate negotiation escapes this writer but surely Woolworths have not harmed their cause by apparently stepping out of the fray at this time.
Return to home
Research Reports
Staff Researcher: First discovery of a direct molecular link between obesity and type 2 diabetesPractice Development
Neil Johnston: Organisational Amnesia and the Lack of a Curator Inhibits Cultural Progress | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Dispensing errors – a ripple effect of damage | open full screen
Fiona Sartoretto Verna AIAPP: Intensive Exposition without crossing over with a supermarket | open full screen
Information Technology
Dr David More: Weekly Australian Health IT Links – 30th June, 2014Preventive Medicine
If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
Submitted by Neil Johnston on Wed, 23/06/2010 - 18:30.
Rollo's comment about consumers being not quite ready for pharmacy at the checkout as the reason for Corbett moving on is a bit ambiguous.
How then do you explain the growth and acceptance of the "Big Yellow Box" pharmacies?
Groups like Chemist Warehouse have pioneered a model that would encourage Woolworths to stay in the game rather than give up and leave.
I also believe that Woolworths has not abandoned its attempt to own pharmacies and have them in supermarkets.
After all, this process started in 1969, just on 31 years ago.
Why would they give up now?
Submitted by Ian Colclough on Tue, 22/06/2010 - 21:43.
However Gary, Pharmacy-in-Supermarket, Trademark 1347431, is far more important that the trademarks you mentioned. The current application is Woolworth's sixth attempt. It was lodged 23 Feb and the deadline for acceptance is 12 months away. You can be sure a new application will be lodged around March 2011 if the current one fails examination.
Submitted by Rollo on Tue, 22/06/2010 - 16:01.
You make it sound as though R Corbett alone was the charge for pharmacy in Woolworths. Surely the decididng factor for such a group would be the consumer. The sense that consumers were not quite ready for pharmacies at the checkout may have been more the reason rather than Corbett moving on. If the consumer charter of service in the 5th Agreement does not force many non performing pharmacies to perform then you can be sure pharmacy will be back on the Woolworths agenda. Beware the sleeping giant.
Post new comment